Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
8,72 USD | +2,59% | +14,59% | +113,73% |
Attività
Numero di dipendenti: 328
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 13/07/18 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 01/09/18 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 10/04/23 |
Shanna Peek
COO | Chief Operating Officer | - | 01/07/19 |
Edward Rebar
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/03/20 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/11/18 |
Ke Liu
LAW | General Counsel | - | 06/01/21 |
Sonja Schrepfer
PRN | Corporate Officer/Principal | 49 | 01/02/19 |
Steven Goldman
PRN | Corporate Officer/Principal | 66 | 01/10/20 |
Terry Fry
PRN | Corporate Officer/Principal | 57 | 01/08/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 69 | 01/05/20 | |
Patrick Yang
BRD | Director/Board Member | 75 | 01/10/18 |
Robert Nelsen
FOU | Founder | 60 | 13/07/18 |
Douglas Cole
BRD | Director/Board Member | 63 | 01/04/20 |
Steven Harr
FOU | Founder | 53 | 13/07/18 |
Josh Bilenker
BRD | Director/Board Member | 52 | 08/01/21 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/11/18 |
Hans Bishop
FOU | Founder | 59 | 13/07/18 |
Michelle Seitz
BRD | Director/Board Member | 59 | 01/12/20 |
Alise Reicin
BRD | Director/Board Member | 63 | 01/12/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 218 835 612 | 198 786 916 ( 90,84 %) | 0 | 90,84 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+113,73% | 1,93 Mrd | |
+1,51% | 42,75 Mrd | |
+8,57% | 41,34 Mrd | |
+49,22% | 41,61 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione SANA
- Società Sana Biotechnology, Inc.